Biotron Limited (BIT) ORDINARY FULLY PAID |
Health Care |
$3 |
Letter to Shareholders
|
11 Jul 2024 10:35AM |
$0.039 |
$0.002 |
fallen by
94.87%
|
|
Metallica Minerals Limited (MLM) ORDINARY FULLY PAID |
Materials |
- |
Change in substantial holding
|
11 Jul 2024 10:29AM |
$0.022 |
$0.034 |
risen by
54.55%
|
|
Austco Healthcare Limited (AHC) ORDINARY FULLY PAID |
Health Care |
$122 |
Austco Healthcare Trading Update
|
11 Jul 2024 10:26AM |
$0.195 |
$0.335 |
risen by
71.79%
|
|
AHC - Price-sensitive ASX Announcement
Full Release
Key Points
- Austco Healthcare Limited expects FY24 revenue to be around $58 million.
- The projected FY24 revenue represents a 38% increase from FY23 revenue of $42 million.
- EBITDA for FY24 is anticipated to be between $7.5 million to $8 million.
- The expected EBITDA increase compared to FY23 is between 108% and 122%.
- The full-year audited results will be announced by 29 August 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Katana Capital Limited (KAT) ORDINARY FULLY PAID |
Financials |
$38 |
Net Tangible Asset Backing 30 June 2024
|
11 Jul 2024 10:23AM |
$1.210 |
$1.225 |
risen by
1.24%
|
|
Macarthur Minerals Limited (MIO) ORDINARY FULLY PAID |
Materials |
$4 |
Proposed issue of securities - MIO
|
11 Jul 2024 10:23AM |
$0.068 |
$0.022 |
fallen by
67.65%
|
|
Macarthur Minerals Limited (MIO) ORDINARY FULLY PAID |
Materials |
$4 |
Private Placement Funding
|
11 Jul 2024 10:23AM |
$0.068 |
$0.022 |
fallen by
67.65%
|
|
MIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Macarthur Minerals Limited announced a private placement to raise AUD $2 million.
- The private placement targets sophisticated, professional, and institutional investors at AUD 0.053 per share.
- One attaching option will be provided for every two placement shares issued, with an exercise price of AUD 0.10 expiring 24 months from issuance.
- Proceeds will fund working capital and operational expenses for the Lake Giles magnetite project.
- The offering requires regulatory approvals from ASX and TSXV, and potential shareholder approval for over subscriptions.
- A 7% fee on gross proceeds and a $5,500 settlement fee will be applied, with 180 Markets managing the placement.
- Macarthur Minerals plans to collaborate with Golden Valley on the Lake Giles Ularring Hematite Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
TZ Limited (TZL) ORDINARY FULLY PAID |
Information Technology |
$15 |
Investor Presentation
|
11 Jul 2024 10:22AM |
$0.024 |
$0.054 |
risen by
125%
|
|
QPM Energy Limited (QPM) ORDINARY FULLY PAID |
Materials |
$94 |
$8m International Partnerships Critical Minerals Grant Award
|
11 Jul 2024 10:22AM |
$0.033 |
$0.033 |
fallen by
0%
|
|
QPM - Price-sensitive ASX Announcement
Full Release
Key Points
- QPM has been awarded an $8m grant from the Australian Federal Government under the International Partnerships in Critical Minerals program.
- Discussions with commercial partners and the Queensland Government to secure the funding required to support the grant are ongoing.
- The TECH Project is in its final commercial validation stage, which involves test work, piloting, and engineering to produce a high-quality Bankable Feasibility Study.
- The matching funding required to support this grant will be independently sourced.
- The grant represents a significant step toward achieving commercial validation of the TECH Project.
- QPM aims to secure funding from independent, external parties to avoid impacting its Gas and Energy Business.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Magellan Global Fund (Open Class) (Managed Fund) (MGOC) |
Financials |
$7,108 |
Effective Date of Conversion
|
11 Jul 2024 10:19AM |
$3.040 |
$3.110 |
risen by
2.30%
|
|
Renascor Resources Limited (RNU) ORDINARY FULLY PAID |
Materials |
$148 |
Renascor Awarded $5m Government Grant
|
11 Jul 2024 10:17AM |
$0.087 |
$0.058 |
fallen by
33.33%
|
|
RNU - Price-sensitive ASX Announcement
Full Release
Key Points
- Renascor Resources Limited has been awarded a $5 million grant.
- The grant is from the Australian Government’s International Partnerships in Critical Minerals Program.
- The grant will co-fund up to 49.9% of the capital cost for a $10 million demonstration processing plant.
- The plant will produce battery-grade Purified Spherical Graphite (PSG) for lithium-ion battery anodes.
- Support for the grant application was provided by POSCO International and Hanwa Co. Ltd.
- The facility will process Graphite Concentrates from Renascor’s Siviour Graphite Deposit in South Australia.
- The grant aims to demonstrate the eco-friendly, hydrofluoric acid-free PSG process.
- Renascor is engaged in a competitive Early Contractor Involvement process for its Siviour Mine and Concentrator.
- Discussions are ongoing with lithium-ion battery market participants for potential offtake terms and equity investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Jervois Global Limited (JRV) ORDINARY FULLY PAID |
Materials |
$30 |
Jervois presents at U.S. House Select Committee roundtable
|
11 Jul 2024 10:17AM |
$0.019 |
$0.011 |
fallen by
42.11%
|
|
Melbana Energy Limited (MAY) ORDINARY FULLY PAID |
Energy |
$78 |
Webinar for Block 9 Update
|
11 Jul 2024 10:12AM |
$0.026 |
$0.023 |
fallen by
11.54%
|
|
Magellan Global Fund (MGF) ORDINARY FULLY PAID |
Financials |
- |
Effective Date of Conversion and proposed de-listing
|
11 Jul 2024 10:12AM |
$2.200 |
$2.210 |
risen by
0.45%
|
|
Power Minerals Limited (PNN) ORDINARY FULLY PAID |
Materials |
$8 |
Proposed issue of securities - PNN
|
11 Jul 2024 10:10AM |
$0.145 |
$0.056 |
fallen by
61.38%
|
|
PNN - Price-sensitive ASX Announcement
Full Release
Key Points
- Power Minerals Limited (PNN) announced a proposed issue of 357,142 ordinary fully paid securities.
- The proposed issue price is AUD 0.140 per security.
- The issue is intended to be a placement to Heng Li as per the announcement on 11 June 2024.
- The proposed issue date is 8 January 2025.
- No external approvals are required for the proposed issue to proceed.
- The total securities are being issued under the entity's 15% placement capacity under listing rule 7.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Thor Energy Plc (THR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$6 |
Substantial Holder Notice
|
11 Jul 2024 10:08AM |
$0.016 |
$0.009 |
fallen by
43.75%
|
|
Power Minerals Limited (PNN) ORDINARY FULLY PAID |
Materials |
$8 |
Binding Funding and Development Agreement for Pular Project
|
11 Jul 2024 10:01AM |
$0.145 |
$0.056 |
fallen by
61.38%
|
|
PNN - Price-sensitive ASX Announcement
Full Release
Key Points
- Power Minerals Limited has signed a Binding Term Sheet (BTS) with Heng Li Technology (HENG LI) for the Pular Project
- HENG LI will invest US$50,000 in Power
- Both parties will enter a formal joint venture (Pular JV) following a successful six-month due diligence period
- Power will handle all permitting and approvals for the project
- HENG LI will provide lithium extraction technology and equipment
- HENG LI will purchase all lithium chloride or lithium carbonate produced
- HENG LI's technology combines direct lithium extraction (DLE) and evaporation, aiming for cost, water, and energy efficiency
- The BTS is a significant step for Power in developing the Salta Lithium Project into large-scale operations
- This agreement adds to Power's funding and development deals for Incahuasi and Rincon Projects
- Next steps include due diligence and formalizing the transaction agreement
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
JB Hi-Fi Limited (JBH) ORDINARY FULLY PAID |
Consumer Discretionary |
$12,079 |
ACCC Proceedings against The Good Guys
|
11 Jul 2024 10:00AM |
$64.790 |
$110.480 |
risen by
70.52%
|
|
Airtasker Limited (ART) ORDINARY FULLY PAID |
Communication Services |
$132 |
Notification regarding unquoted securities - ART
|
11 Jul 2024 10:00AM |
$0.300 |
$0.290 |
fallen by
3.33%
|
|
Duxton Farms Ltd (DBF) ORDINARY FULLY PAID |
Consumer Staple |
$43 |
Application for quotation of securities - DBF
|
11 Jul 2024 9:59AM |
$1.470 |
$1.050 |
fallen by
28.57%
|
|
Xpon Technologies Group Limited (XPN) ORDINARY FULLY PAID |
Information Technology |
$4 |
XPON Investor Q&A Webinar
|
11 Jul 2024 9:59AM |
$0.012 |
$0.010 |
fallen by
16.67%
|
|
Origin Energy Limited (ORG) ORDINARY FULLY PAID |
Utilities |
$20,122 |
Notification of cessation of securities - ORG
|
11 Jul 2024 9:59AM |
$10.650 |
$11.680 |
risen by
9.67%
|
|
Zelira Therapeutics Limited (ZLD) ORDINARY FULLY PAID |
Health Care |
$5 |
ZLD Advances HOPE Autism Drug Program with U.S FDA Meeting
|
11 Jul 2024 9:58AM |
$0.480 |
$0.410 |
fallen by
14.58%
|
|
ZLD - Price-sensitive ASX Announcement
Full Release
Key Points
- Zelira Therapeutics Ltd advances HOPE® autism drug program after successful meeting with the FDA.
- FDA provided clear and positive responses to preliminary questions from Zelira Therapeutics.
- The focus is on treating irritability associated with Autism Spectrum Disorder (ASD) in patients with Phelan-McDermid Syndrome and Smith-Magenis Syndrome.
- FDA guidance was given for the Phase 1 study design in healthy volunteers to assess safety and pharmacokinetics.
- Zelira Therapeutics is moving towards an Investigational New Drug (IND) submission following the meeting.
- The meeting included stakeholders like iNGENu CRO who significantly contributed to the discussions.
- Zelira Therapeutics expresses enthusiasm for the FDA's prompt and detailed guidance, which is crucial for the development of the HOPE® program.
- Zelira looks forward to receiving official FDA meeting notes to guide the next steps in the IND submission process.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Aurizon Holdings Limited (AZJ) ORDINARY FULLY PAID |
Industrials |
$5,549 |
AXX: Aurizon's acq of Flinders Logistics raises concerns
|
11 Jul 2024 9:58AM |
$3.600 |
$3.170 |
fallen by
11.94%
|
|
Metrics Master Income Trust (MXT) ORDINARY UNITS FULLY PAID |
Financials |
$2,517 |
June 2024 Monthly Report
|
11 Jul 2024 9:56AM |
$2.060 |
$2.060 |
fallen by
0%
|
|
Origin Energy Limited (ORG) ORDINARY FULLY PAID |
Utilities |
$20,122 |
Notification regarding unquoted securities - ORG
|
11 Jul 2024 9:56AM |
$10.650 |
$11.680 |
risen by
9.67%
|
|